Waters Corp WAT
HEALTHCARE · DIAGNOSTICS & RESEARCHi
Market dataready · fetched 2026-11-03T15:56:13.369Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-03T15:56:08.860816266Z
FundamentalsAlpha Vantage · ready · quarter 2026-06-30 · fetched 2026-11-03T15:56:12.448832+00:00
Waters Corp options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 504.50 | 34.7% | 7.9% | 436.81 | 45.2% | 8.4% |
| 25Δ | 498.69 | 35.5% | 7.0% | 444.01 | 44.9% | 7.2% |
| 30Δ | 493.32 | 36.0% | 6.2% | 451.66 | 42.5% | 5.9% |
| 35Δ | 488.21 | 36.7% | 5.5% | 457.87 | 41.1% | 5.0% |
| 40Δ | 483.51 | 37.9% | 4.9% | 463.44 | 40.2% | 4.2% |
| 45Δ | 478.74 | 39.0% | 4.4% | 468.69 | 39.6% | 3.5% |
| 50Δ | 473.74 | 40.0% | 3.9% | 473.69 | 38.9% | 3.0% |
| 55Δ | 468.64 | 40.9% | 3.4% | 478.60 | 38.3% | 2.4% |
| 60Δ | 463.23 | 41.6% | 2.9% | 483.07 | 36.8% | 2.0% |
| 65Δ | 457.55 | 42.3% | 2.5% | 487.35 | 35.1% | 1.5% |
| 70Δ | 451.47 | 43.1% | 2.1% | 491.94 | 33.9% | 1.1% |
| 75Δ | 444.27 | 44.5% | 1.7% | 497.03 | 33.4% | 0.8% |
| 80Δ | 435.85 | 46.4% | 1.4% | 502.07 | 32.4% | 0.5% |
20Δ
- Pseudo strike
- 504.50
- IV
- 34.7%
- B/E move
- 7.9%
- Pseudo strike
- 436.81
- IV
- 45.2%
- B/E move
- 8.4%
25Δ
- Pseudo strike
- 498.69
- IV
- 35.5%
- B/E move
- 7.0%
- Pseudo strike
- 444.01
- IV
- 44.9%
- B/E move
- 7.2%
30Δ
- Pseudo strike
- 493.32
- IV
- 36.0%
- B/E move
- 6.2%
- Pseudo strike
- 451.66
- IV
- 42.5%
- B/E move
- 5.9%
35Δ
- Pseudo strike
- 488.21
- IV
- 36.7%
- B/E move
- 5.5%
- Pseudo strike
- 457.87
- IV
- 41.1%
- B/E move
- 5.0%
40Δ
- Pseudo strike
- 483.51
- IV
- 37.9%
- B/E move
- 4.9%
- Pseudo strike
- 463.44
- IV
- 40.2%
- B/E move
- 4.2%
45Δ
- Pseudo strike
- 478.74
- IV
- 39.0%
- B/E move
- 4.4%
- Pseudo strike
- 468.69
- IV
- 39.6%
- B/E move
- 3.5%
50Δ
- Pseudo strike
- 473.74
- IV
- 40.0%
- B/E move
- 3.9%
- Pseudo strike
- 473.69
- IV
- 38.9%
- B/E move
- 3.0%
55Δ
- Pseudo strike
- 468.64
- IV
- 40.9%
- B/E move
- 3.4%
- Pseudo strike
- 478.60
- IV
- 38.3%
- B/E move
- 2.4%
60Δ
- Pseudo strike
- 463.23
- IV
- 41.6%
- B/E move
- 2.9%
- Pseudo strike
- 483.07
- IV
- 36.8%
- B/E move
- 2.0%
65Δ
- Pseudo strike
- 457.55
- IV
- 42.3%
- B/E move
- 2.5%
- Pseudo strike
- 487.35
- IV
- 35.1%
- B/E move
- 1.5%
70Δ
- Pseudo strike
- 451.47
- IV
- 43.1%
- B/E move
- 2.1%
- Pseudo strike
- 491.94
- IV
- 33.9%
- B/E move
- 1.1%
75Δ
- Pseudo strike
- 444.27
- IV
- 44.5%
- B/E move
- 1.7%
- Pseudo strike
- 497.03
- IV
- 33.4%
- B/E move
- 0.8%
80Δ
- Pseudo strike
- 435.85
- IV
- 46.4%
- B/E move
- 1.4%
- Pseudo strike
- 502.07
- IV
- 32.4%
- B/E move
- 0.5%
Options history
Table
| Date | IV (%) |
|---|---|
| 33.61% | |
| 32.43% | |
| 31.35% | |
| 32.30% | |
| 31.18% | |
| 30.68% | |
| 32.17% | |
| 31.08% | |
| 32.74% | |
| 34.09% | |
| 34.57% | |
| 38.11% | |
| 33.02% | |
| 34.46% | |
| 32.75% | |
| 32.51% | |
| 31.23% | |
| 30.14% | |
| 31.35% | |
| 31.89% | |
| 31.09% | |
| 31.45% | |
| 30.62% | |
| 33.90% | |
| 33.55% | |
| 34.59% | |
| 32.82% | |
| 34.17% | |
| 36.20% | |
| 35.59% | |
| 34.95% | |
| 32.20% | |
| 32.17% | |
| 31.79% | |
| 32.27% | |
| 32.04% | |
| 31.42% | |
| 31.37% | |
| 31.48% | |
| 32.39% | |
| 33.68% | |
| 32.70% | |
| 32.68% | |
| 33.09% | |
| 33.35% | |
| 34.08% | |
| 33.80% | |
| 35.85% | |
| 36.65% | |
| 37.16% | |
| 38.98% | |
| 35.34% | |
| 35.61% | |
| 35.86% | |
| 34.91% | |
| 36.17% | |
| 36.59% | |
| 37.17% | |
| 36.58% | |
| 36.89% | |
| 36.52% | |
| 40.84% |
Diagnostics & Research
WGS
Sema4 Holdings Corp. The company is headquartered in Stamford, Connecticut.
More →XGN
Exagen Inc. develops and markets various test products based on its Cell-Bound Complement Activation Products technology under the AVISE brand name in the United States. The…
More →A
Agilent Technologies, Inc. is an American analytical instrumentation development and manufacturing company that offers its products and services to markets worldwide. Its global…
More →ADPT
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company is…
More →BLLN
BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company is headquartered in Menlo Park, California.
More →CDNA
CareDx, Inc. discovers, develops and markets diagnostic solutions for transplant patients and caregivers globally. The company is headquartered in South San Francisco, California.
More →